All Stories

  1. An investigation into the statistical precision attainable with a distribution-free method of constructing age-dependent reference centiles
  2. Reference ranges: Why tolerance intervals should not be used. Comment on Liu, Bretz and Cortina-Borja, Reference range: Which statistical intervals to use? SMMR, 2021,Vol. 30(2) 523–534
  3. Allowing for stratification in sample size planning of two-arm trials with continuous or binary outcome: Overview and tutorial
  4. Testing for goodness rather than lack of fit of continuous probability distributions
  5. Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten’s to the Letter to the editor Re: results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (P...
  6. Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
  7. Is the p-Value a Suitable Basis for the Construction of Measures of Evidence? Comment on “The Role of p-Values in Judging the Strength of Evidence and Realistic Replication Expectations”
  8. Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
  9. Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
  10. On powerful exact nonrandomized tests for the Poisson two-sample setting
  11. Planning and Analysis of Trials Using a Stepped Wedge Design: Part 26 of a Series on Evaluation of Scientific Publications
  12. Testing for goodness rather than lack of fit of an X–chromosomal SNP to the Hardy-Weinberg model
  13. Author response to the contributors to the discussion on “A critical evaluation of the current ‘p -value controversy’”
  14. Sample size planning of two-arm superiority and noninferiority survival studies with discrete follow-up
  15. A critical evaluation of the current “p-value controversy”
  16. Equivalence Testing With Particle Size Distribution Data: Methods and Applications in the Development of Inhalative Drugs
  17. A U -statistics based approach to sample size planning of two-arm trials with discrete outcome criterion aiming to establish either superiority or noninferiority
  18. Prenatal Risk Calculation (PRC) 3.0: An Extended DoE-Based First-Trimester Screening Algorithm Allowing For Early Blood Sampling
  19. PREFERE-Studie im Aufwind
  20. Normal Doppler Reference Values of the Pericallosal Artery
  21. Testing for noninferiority of binomial distributions referring to a modified equivalence region with piecewise linear boundary
  22. Nearly exact sample size calculation for powerful non-randomized tests for differences between binomial proportions
  23. A comparison of region-of-interest measures for extracting whole brain data using survival analysis in alcoholism as an example
  24. Multivariate Equivalence Tests for Use in Pharmaceutical Development
  25. Determination of reference limits: statistical concepts and tools for sample size calculation
  26. Biometry of the fetal corpus callosum by three‐dimensional ultrasound
  27. The Place of Additional Individual Psychotherapy in the Treatment of Alcoholism: A Randomized Controlled Study in Nonresponders to Anticraving Medication—Results of the PREDICT Study
  28. Advanced dynamic Doppler flow of the pulmonary artery in a normal population: reference values from 18 to 41 weeks of gestation calculated by automatic Doppler waveform analysis
  29. PREFERE – die Deutsche Prostatakrebsstudie
  30. PREFERE – die Deutsche Prostatakrebsstudie
  31. Die Bedeutung der Pathologie in der deutschen Prostatakrebsstudie PREFERE
  32. Implementing Panic-Focused Psychodynamic Psychotherapy into Clinical Practice
  33. PREFERE – die Deutsche Prostatakrebsstudie
  34. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study
  35. Establishing Equivalence or Non-Inferiority in Clinical Trials
  36. A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI
  37. On the Proper Use of the Crossover Design in Clinical Trials
  38. Blood Flow Velocity Waveforms of the Umbilical Artery in a Normal Population: Reference Values from 18 Weeks to 42 Weeks of Gestation
  39. Reference Values for Blood Flow Velocity in the Uterine Artery in Normal Pregnancies from 18 Weeks to 42 Weeks of Gestation Calculated by Automatic Doppler Waveform Analysis
  40. Cochran-Armitage Test versus Logistic Regression in the Analysis of Genetic Association Studies
  41. Fetal Lung Volume Measurements using 3D Ultrasonography
  42. On easily interpretable multivariate reference regions of rectangular shape
  43. Individualized Correction for Maternal Weight in Calculating the Risk of Chromosomal Abnormalities with First-Trimester Screening Data
  44. Investigating Hardy–Weinberg equilibrium in case–control or cohort studies or meta-analysis
  45. Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity
  46. ERRATUM
  47. Testing Statistical Hypotheses of Equivalence and Noninferiority
  48. Exact linear rank tests for two-sample equivalence problems with continuous data
  49. A Confidence-Limit-Based Approach to the Assessment of Hardy-Weinberg Equilibrium
  50. Adapting the logical basis of tests for Hardy-Weinberg Equilibrium to the real needs of association studies in human and medical genetics
  51. Searching for Responders to Acamprosate and Naltrexone in Alcoholism Treatment: Rationale and Design of thePredict Study
  52. A Genotype-Based Approach to Assessing the Association between Single Nucleotide Polymorphisms
  53. A New Approach to Calculating the Risk of Chromosomal Abnormalities with First-Trimester Screening Data
  54. Systematic Analysis of Glutamatergic Neurotransmission Genes in Alcohol Dependence and Adolescent Risky Drinking Behavior
  55. Transvaginale Ultraschallbiometrie in der Frühgravidität - Ein Wachstumsmodell
  56. Das normale fetale Wachstumsprofil - ein einheitliches Modell zur Berechnung von Normkurven für die gängigen Kopf- und Abdomenparameter sowie die großen Extremitätenknochen
  57. Orbitadurchmesser, innerer und äußerer Orbitaabstand
  58. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression
  59. Stratification of medulloblastoma on the basis of histopathological grading
  60. Zur klinischen Relevanz von Cholinesterase-Inhibitoren bei Alzheimer Krankheit - Eine klinische und biometrische Kritik der AD2000-Studie
  61. Complete long‐term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer
  62. Genotype-Phenotype Studies in Bipolar Disorder Showing Association Between the DAOA/G30 Locus and Persecutory Delusions: A First Step Toward a Molecular Genetic Classification of Psychiatric Phenotypes
  63. Adjuvant Cisplatin Plus Methotrexate Versus Methotrexate, Vinblastine, Epirubicin, and Cisplatin in Locally Advanced Bladder Cancer: Results of a Randomized, Multicenter, Phase III Trial (AUO-AB 05/95)
  64. Statistical Methods for the Analysis of Two‐Arm Non‐inferiority Trials with Binary Outcomes
  65. A new approach to sample size calculation for reference interval studies
  66. Tests for Establishing Compatibility of an Observed Genotype Distribution with Hardy-Weinberg Equilibrium in the Case of a Biallelic Locus
  67. Statistical confirmation of negative results of association studies in genetic epidemiology
  68. Analysis of genetic variations of protein tyrosine kinase fyn and their association with alcohol dependence in two independent cohorts
  69. No association of alcohol dependence with a NMDA-receptor 2B gene variant
  70. REWARD CRAVING AND WITHDRAWAL RELIEF CRAVING: ASSESSMENT OF DIFFERENT MOTIVATIONAL PATHWAYS TO ALCOHOL INTAKE
  71. Testing Statistical Hypotheses of Equivalence
  72. Knowledge about Glaucoma in the Unselected Population: A German Survey
  73. The Neuronal Nitric Oxide Synthase Gene Is Critically Involved in Neurobehavioral Effects of Alcohol
  74. Relationship between Cortisol and Serotonin Metabolites and Transporters in Alcolholism
  75. Blood flow velocity waveforms of the fetal middle cerebral artery in a normal population: reference values from 18 weeks to 42 weeks of gestation
  76. Age-Related Reference Regions for Longitudinal Measurements of Growth Characteristics
  77. Reference values of fetal aortic flow velocity waveforms and associated intra‐observer reliability in normal pregnancies
  78. Age-Related Reference Ranges for Fetal Foot Length
  79. Bayesian Construction of an Improved Parametric Test for Probability-Based Individual Bioequivalence
  80. Long term follow-up of combined radiochemotherapy for locally advanced bladder carcinoma
  81. On a reasonable disaggregate criterion of population bioequivalence admitting of resampling-free testing procedures
  82. Reference values of ductus venosus flow velocities and calculated waveform indices
  83. A Distribution-Free Two-Sample Equivalence Test Allowing for Tied Observations
  84. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study
  85. A comment on so-called individual criteria of bioequivalence
  86. Testing for Absence of Qualitative Interactions Between Risk Factors and Treatment Effects
  87. Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder: Prognostic impact of lymph node involvement
  88. A New Approach to Equivalence Assessment in Standard Comparative Bioavailability Trials by Means of the Mann‐Whitney Statistic
  89. Sonographic size of uterus and ovaries in pre‐ and postmenopausal women
  90. Age-Related Reference Ranges for Growth Parameters
  91. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International society of paediatric oncology (SIOP) and the (German) society of paediatric oncology (GPO): SIOP II
  92. Sonographische Normkurven des fetalen knöchernen Thorax und der fetalen Lunge
  93. Adjuvant Polychemotherapy of Nonorgan-Confined Bladder Cancer After Radical Cystectomy Revisited: Long-Term Results of a Controlled Prospective Study and Further Clinical Experience
  94. Factors influencing survival after resection of pancreatic cancer. A DNA analysis and a histomorphologic study
  95. Prognostic value of DNA analysis in colorectal carcinoma
  96. A Log-Rank Test for Equivalence of Two Survivor Functions
  97. Basing the Analysis of Comparative Bioavailability Trials on an Individualized Statistical Definition of Equivalence
  98. DNA image cytometry in stomach carcinoma. Its relation to histomorphologic parameters and its influence on prognosis
  99. Advanced Bladder Cancer (Stages pT3b, pT4a, pN1 and pN2): Improved Survival after Radical Cystectomy and 3 Adjuvant Cycles of Chemotherapy. Results of a Controlled Prospective Study
  100. Vergleich der DNS-Analyse mit histomorphologischen parametern beim Magenkarzinom
  101. Diagnosis, Therapeutic Strategy and Prognosis of Acute Mesenteric Vascular Occlusion: Results of a Consecutive Series
  102. Fortgeschrittenes Blasenkarzinom (Stadien pT3b, pT4a, pN1, pN2)
  103. Elements of Significance Testing with Equivalence Problems
  104. Hydrochlorothiazide and Verapamil in the Treatment of Hypertension
  105. Hemodynamics During PEEP Ventilation in Patients with Severe Left Ventricular Failure Studied by Transesophageal Echocardiography
  106. Reference Standards for Software Evaluation
  107. On the use of asymptotic expansion in computing the null distribution of page's L-statistic
  108. Die Medulloblastom-Therapiestudien MBL 80* und MED 84** der Gesellschaft für Pädiatrische Onkologie (GPO) und der Société Internationale d'Oncologie Pédiatrique (SIOP)